Translational research on a prospective observational study of atezolizumab in patients with triple-negative breast cancer (JBCRG-C08)
Not Applicable
- Conditions
- Triple-negative Breast cancer
- Registration Number
- JPRN-UMIN000045279
- Lead Sponsor
- Cancer Institute Hospital of JFCR Breast Oncology Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Paitients excluded from ATTRIBUTE trial(UMIN000041747)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method